BuzzSparks.org

Ultragenyx Pharmaceutical


Ultragenyxâ„¢ develops therapeutics for rare diseases, sometimes referred to as Orphan products. Founded in 2010, the company is led by Emil Kakkis, M.D., Ph.D., former CMO of BioMarin Pharmaceutical. Efficient and effective development strategies...

Homepage:
Total money raised: $120M

94949 77 Digital Drive
Suite 210

Novato
Novato
USA CA

Phone: 415.884.0223 x107

Emil D. Kakkis President & CEO
Shalini Sharp SVP Finance & CFO
Thomas Kassberg Chief Business Officer and Senior Vice President
Ben Auspitz Director
Past

December, 2012

Ultragenyx Pharmaceutical raised $75M in private_equity round

SEC    sec.gov

June, 2011

Ultragenyx Pharmaceutical raised $45M in a Series A round from TPG Biotechnology Partners, Fidelity Biosciences, HealthCap, and Pappas Ventures

Ultragenyx Pharmaceutical Closes $45M Series A Financing    finsmes.com